BALAXI logo

Balaxi Pharmaceuticals Limited Stock Price

NSEI:BALAXI Community·₹2.4b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author

BALAXI Share Price Performance

₹42.79
-47.18 (-52.44%)
₹42.79
-47.18 (-52.44%)
Price ₹42.79

BALAXI Community Narratives

There are no narratives available yet.

Snowflake Analysis

Adequate balance sheet with low risk.

3 Risks
1 Reward

Balaxi Pharmaceuticals Limited Key Details

₹3.0b

Revenue

₹1.7b

Cost of Revenue

₹1.3b

Gross Profit

₹1.1b

Other Expenses

₹188.8m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
3.42
43.78%
6.34%
23.1%
View Full Analysis

About BALAXI

Founded
1942
Employees
600
CEO
Ashish Maheshwari
WebsiteView website
balaxipharma.in

Balaxi Pharmaceuticals Limited engages in the international wholesale distribution of pharmaceuticals, builders hardware, and FMCG products in India, Africa, and Latin America. The company offers pharmaceutical products across various therapeutic areas, including antibiotics, analgesic, anti-malaria, and others. It also provides biscuits and toothpaste. The company was formerly known as Balaxi Ventures Limited and changed its name to Balaxi Pharmaceuticals Limited in October 2020. The company was incorporated in 1942 and is headquartered in Hyderabad, India. Balaxi Pharmaceuticals Limited is a subsidiary of Balaxi Overseas Private Limited.

Recent BALAXI News & Updates

Recent updates

No updates